Clinical Trials in the Developing World:An On-the-Ground Look at Risks and Best Practices
Product Details
The world's largest pharmaceutical companies are conducting nearly half of their clinical trials in developing countries around the world. And while the benefits are great, so are the risks.
Consider the case of Pfizer, currently facing criminal and civil charges over a clinical trial conducted in Nigeria, where children were allegedly given the antibiotic Trovan without informed parental consent. What steps could they have taken to anticipate, and avoid, this unfortunate situation?
There are many unique challenges that you must be prepared to deal with when you're working in developing countries. For example:
- Political and economic turmoil
- Subject dislocation or migration
- Underlying morbidity of subject populations
- Daily living that would be considered adverse events in a developed country context
- Employing study personnel
- Corruption and bribery
It's imperative that you be ready to deal with these unusual risks as well other issues that may develop.
Here's how ...
Sign up your entire team to listen in and discover:
- 10 tips for building the right trial support network
- Eight U.S. and international laws — and norms you need to know
- Six ethical dilemmas you will face
- Eight red flags that something may be going wrong
- A 12-point practical checklist, based on bitter experience, for anticipating and avoiding problems
Register now, reap the benefits and significantly reduce your risk of conducting clinical trial studies in developing countries. Plus, you'll get an opportunity to ask your toughest questions during the Q&A session.